251 related articles for article (PubMed ID: 8157757)
21. Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies.
Galli M; Comfurius P; Barbui T; Zwaal RF; Bevers EM
Thromb Haemost; 1992 Sep; 68(3):297-300. PubMed ID: 1440495
[TBL] [Abstract][Full Text] [Related]
22. Laboratory tests for the antiphospholipid syndrome.
Pericleous C; Ripoll VM; Giles I; Ioannou Y
Methods Mol Biol; 2014; 1134():221-35. PubMed ID: 24497366
[TBL] [Abstract][Full Text] [Related]
23. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
Matsuura E
Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
[TBL] [Abstract][Full Text] [Related]
24. Are immunoglobulins with lupus anticoagulant activity specific for phospholipids?
Pierangeli SS; Harris EN; Gharavi AE; Goldsmith G; Branch DW; Dean WL
Br J Haematol; 1993 Sep; 85(1):124-32. PubMed ID: 8251379
[TBL] [Abstract][Full Text] [Related]
25. Lupus-like anticoagulant properties of murine monoclonal antibodies to beta 2-glycoprotein I.
Arvieux J; Pouzol P; Roussel B; Jacob MC; Colomb MG
Br J Haematol; 1992 Aug; 81(4):568-73. PubMed ID: 1382549
[TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid antibodies and thrombosis.
Brighton TA; Chesterman CN
Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
[TBL] [Abstract][Full Text] [Related]
27. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
28. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
Pengo V; Biasiolo A; Rampazzo P; Brocco T
Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus.
Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Kobayashi S; Koike T
Arthritis Rheum; 1996 Sep; 39(9):1466-74. PubMed ID: 8814057
[TBL] [Abstract][Full Text] [Related]
30. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
31. Role of beta 2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune disease.
Dueymes M; Piette JC; Le Tonquèze M; Bendaoud B; Roué R; Garré M; Youinou P
Lupus; 1995 Dec; 4(6):477-81. PubMed ID: 8749571
[TBL] [Abstract][Full Text] [Related]
32. The antiphospholipid antibodies.
Tanaseanu C; Moldoveanu E; Tanaseanu S; Popescu LM
Haematologia (Budap); 2002; 31(4):287-302. PubMed ID: 12038512
[TBL] [Abstract][Full Text] [Related]
33. Anticardiolipin and anti-beta 2glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome.
Tincani A; Balestrieri G; Spatola L; Cinquini M; Meroni PL; Roubey RA
Clin Exp Rheumatol; 1998; 16(4):396-402. PubMed ID: 9706418
[TBL] [Abstract][Full Text] [Related]
34. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
35. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays.
Raby A; Moffat K; Crowther M
Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants.
Arnout J; Vermylen J
Lupus; 1998; 7 Suppl 2():S23-8. PubMed ID: 9814667
[TBL] [Abstract][Full Text] [Related]
37. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
38. Anticardiolipin antibodies: specificity and function.
Harris EN; Pierangeli S
Lupus; 1994 Aug; 3(4):217-22. PubMed ID: 7804305
[TBL] [Abstract][Full Text] [Related]
39. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis.
Avcin T; Ambrozic A; Bozic B; Accetto M; Kveder T; Rozman' B
Clin Exp Rheumatol; 2002; 20(1):101-8. PubMed ID: 11892692
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies: basic immunology and assays.
Schultz DR
Semin Arthritis Rheum; 1997 Apr; 26(5):724-39. PubMed ID: 9144849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
